Phase 1 QINLOCK Results for Patients with GIST Now Published
Source: pixabay.com

Phase 1 QINLOCK Results for Patients with GIST Now Published

Last week, biopharmaceutical company Deciphera Pharmaceuticals announced results from its Phase 1 clinical trial on QINLOCK (ripretinib). The study, published in the Journal of Clinical Oncology, tested QINLOCK as a potential…

Continue Reading Phase 1 QINLOCK Results for Patients with GIST Now Published

Scientists Find an Array of Genes That May Lead to Precision Therapies for Various Types of Autism

According to an article in the publication Labroots, autism spectrum disorder (ASD) may be the result of interaction between environmental and genetic factors. For instance, researchers point out that ASD…

Continue Reading Scientists Find an Array of Genes That May Lead to Precision Therapies for Various Types of Autism